Delivery Order SPE2DR25D1104-SPE2DR26FL039
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,402.26 to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (100 count) on January 28, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price, non-set-aside contract is performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,040.73 to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets (100-count) on May 12, 2025, with an ultimate completion date of May 13, 2025. This firm fixed-price, non-competitive delivery order represents a single pharmaceutical supply transaction under AmerisourceBergen's broader federal contract portfolio. The product will be delivered to the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,258.58 delivery order to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (500 count) on July 31, 2025, with completion expected by August 1, 2025. This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $1,043.53 firm fixed price delivery order to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets (100 count) on July 28, 2025, with completion scheduled for July 29, 2025. This competitive award, issued without set-aside designation, is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $1,122.18 to AmerisourceBergen Drug Corp for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (500 count) on November 20, 2025, with an ultimate completion date of November 21, 2025. The contract utilizes firm fixed-price pricing and is not designated as a set-aside award, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,615.32 delivery order to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets (100 count) on December 29, 2025, with an ultimate completion date of December 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a $1,421.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets in quantities of 100 units. The contract, which is non-set-aside and competitively awarded, is scheduled for completion by January 7, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction...
- The Defense Logistics Agency awarded a delivery order valued at $9,373.17 to AmerisourceBergen Drug Corp for butalbital-acetaminophen-caffeine 50-325-40mg tablets (100 count) on July 29, 2025, with an ultimate completion date of July 30, 2025. This non-set-aside, competitively awarded contract was issued under firm fixed-price terms and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The product being supplied is a combination pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,427.28 to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets (100-count packaging). This firm fixed-price, non-competitive delivery order was awarded on December 5, 2025, with an ultimate completion date of December 8, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $4,242.27 delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (100 count). This firm fixed price delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FL039Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,108.46 to AmerSourceBergen Drug Corp for the supply of Butalbital-Acetaminophen-Caffeine 50-300-40 mg tablets (100 count) on January 27, 2026, with an ultimate completion date of January 28, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order falls under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerSourceBergen, operating as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. The parent company's substantial IDC with DLA encompasses an extensive portfolio of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This particular delivery order for butalbital-based pain management medication represents a routine fulfillment under the larger contract vehicle, demonstrating the contractor's ongoing capability to efficiently supply essential pharmaceutical commodities required by military treatment facilities and federal healthcare institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/26/26 |